| Literature DB >> 33603075 |
Heekyoung Kang1,2,3, Hae-Jin Sohn1,2, A-Young Park1,2, A-Jeong Ham1,2, Jeong-Heon Lee1,2, Young-Hwan Oh1,2, Yong-Joon Chwae1,2, Kyongmin Kim1,2, Sun Park1,2, Hongseok Yang4, Suk-Yul Jung5, Jong-Hyun Kim6, Ho-Joon Shin7,8.
Abstract
Acanthamoeba castellanii, the causative agent of Acanthamoeba keratitis (AK), occurs mainly in contact lens users with poor eye hygiene. The findings of many in vitro studies of AK, as well as the testing of therapeutic drugs, need validation in in vivo experiments. BALB/c mice were used in this study to establish in vivo AK model. A. castellanii cell suspensions (equal mixtures of trophozoites and cysts) were loaded onto 2-mm contact lens pieces and inserted into mouse eyes that were scratched using an ophthalmic surgical blade under anesthesia and the eyelids of the mice were sutured. The AK signs were grossly observed and PCR was performed using P-FLA primers to amplify the Acanthamoeba 18S-rRNA gene from mouse ocular tissue. The experimental AK mouse model was characterized by typical hazy blurring and melting of the mouse cornea established on day 1 post-inoculation. AK was induced with at least 0.3 × 105 A. castellanii cells (optimal number, 5 × 104), and the infection persisted for two months. The PCR products amplified from the extracted mouse eye DNA confirmed the development of Acanthamoeba-induced keratitis during the infection periods. In conclusion, the present AK mouse model may serve as an important in vivo model for the development of various therapeutic drugs against AK.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33603075 PMCID: PMC7892866 DOI: 10.1038/s41598-021-83738-4
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379